Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database

Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

(2021) Alexa B. Kimball et al.   JAMA Dermatology

Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases

(2021) Joseph Meserve et al.   GASTROENTEROLOGY

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

(2021) Emma Flanagan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Inflammatory bowel disease and risk of birth defects in offspring

(2020) Nathalie Auger et al.   Journal of Crohns & Colitis

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases

(2020) Lisa R. Sammaritano et al.   ARTHRITIS CARE & RESEARCH

Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review

(2020) Javier P. Gisbert et al.   DRUGS

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

(2020) Uma Mahadevan et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway – A Report from the American Gastroenterological Association IBD Parenthood Project Working Group

(2019) Uma Mahadevan et al.   GASTROENTEROLOGY

Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies

(2019) Yingjuan Liu et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Birth Outcomes and Disease Activity during Pregnancy in a Prospective Cohort of Women with Psoriatic Arthritis and Ankylosing Spondylitis

(2019) Chelsey J.F. Smith et al.   ARTHRITIS CARE & RESEARCH

Maternal and infant pregnancy outcomes in women with psoriatic arthritis: a Swedish nationwide cohort study

(2019) K Remaeus et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Biologics exposure during pregnancy and breastfeeding in a psoriasis patient

(2019) Cristina Mugheddu et al.   Dermatologic Therapy

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

(2019) Christopher Andrew Lamb et al.   GUT

Exposure to Infliximab During Pregnancy: Post-Marketing Experience

(2019) Anja Geldhof et al.   DRUG SAFETY

Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden

(2018) G Bröms et al.   ACTA DERMATO-VENEREOLOGICA

Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)

(2018) Maxime Luu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions

(2018) Chelsey J. F. Smith et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Relationship between the Clinical Course of Ulcerative Colitis during Pregnancy and the Outcomes of Pregnancy: A Retrospective Evaluation

(2018) Ayumi Ito et al.   INTERNAL MEDICINE

Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system

(2018) Jantien W. Wieringa et al.   Expert Review of Gastroenterology & Hepatology

The Effect of Pregnancy on Disease Activity in Patients with Psoriatic Arthritis

(2018) Mark Berman et al.   JOURNAL OF RHEUMATOLOGY

The Debate is Over: Continue Anti-Tumor Necrosis Factor Therapy Throughout Pregnancy

(2018) Eric J. Mao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease

(2018) Entcho Klenske et al.   Journal of Crohns & Colitis

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

(2017) Uma Mahadevan et al.   GASTROENTEROLOGY

Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis

(2017) Fukiko Komaki et al.   JOURNAL OF AUTOIMMUNITY

Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment

(2017) Chelsey J. Forbess Smith et al.   Birth Defects Research

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies

(2016) R. Bobotsis et al.   BRITISH JOURNAL OF DERMATOLOGY

Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy

(2016) Gabriella Bröms et al.   Clinical Gastroenterology and Hepatology

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

(2015) A de Lima et al.   GUT

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol

(2015) M. E. B. Clowse et al.   JOURNAL OF RHEUMATOLOGY

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes

(2015) Heather A. Boyd et al.   PLoS One

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

(2014) M. Seirafi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies

(2014) A. Munden et al.   BRITISH JOURNAL OF DERMATOLOGY

Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease

(2014) Neeraj Narula et al.   INFLAMMATORY BOWEL DISEASES

Limited Risks of Major Congenital Anomalies in Children of Mothers With IBD and Effects of Medications

(2013) Lu Ban et al.   GASTROENTEROLOGY

Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review

(2013) Renée M Marchioni   WORLD JOURNAL OF GASTROENTEROLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease

(2012) Maria Chaparro et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Fertility in male patients with seronegative spondyloarthropathies treated with infliximab

(2012) Ioanna Saougou et al.   JOINT BONE SPINE

Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006

(2011) A. Bortoli et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patent foramen ovale: anatomy, outcomes and closure

(2011) Patrick A. Calvert et al.   Nature Reviews Cardiology

Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation

(2010) Pauline L. Martin et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden

(2010) Olof Stephansson et al.   INFLAMMATORY BOWEL DISEASES

Fertility and Reproduction in Male Patients with Ankylosing Spondylitis Treated with Infliximab

(2008) Sophia Paschou et al.   JOURNAL OF RHEUMATOLOGY